Stokovic, Nikola
Ivanjko, Natalia
Pecin, Marko
Erjavec, Igor
Smajlović, Ana
Milesevic, Marina
Karlovic, Sven
Capak, Hrvoje
Vrbanac, Zoran
Maticic, Drazen
Vukicevic, Slobodan http://orcid.org/0000-0003-4076-0285
Funding for this research was provided by:
FP7 Health (HEALTH‐F4‐2011‐279239)
H2020 Health (779340)
European Regional Development Fund (KK.01.1.1.01.0008)
Article History
Received: 11 March 2022
Accepted: 15 June 2022
First Online: 8 July 2022
Competing interests
: S.V. is a founder of Genera Research and a coordinator of the EU HORIZON 2020 grant OSTEOproSPINE funding clinical studies of the new drug for bone repair (patent WO2019076484A1). The other authors declare no conflicts of interest.